
What Is Moisture Content Analysis? - Scientist Live
Apr 1, 2013 · Moisture content analysis is a critical component of material quality and essentially a function of quality control in most production and laboratory facilities.
Merck and Opentrons automate the laboratory | Scientist Live
Feb 7, 2025 · A partnership between life sciences companies Millipore Sigma and Opentrons Labworks will enable the automation of assay kits on a custom Opentrons Flex workstation.. Scientists and engineers will develop and verify platform workflows, automation-enabled assays from Merck, Millipore’s parent company. “Our customers are prioritising tools and technologies that improve reproducibility and ...
Illumina launches pilot proteomics programme | Scientist Live
Feb 3, 2025 · Proteomics, the study of proteins and their cellular activities, enables researchers to understand the role of proteins in health and disease and can facilitate biomarker discovery for conditions such as cancer and cardiovascular disease.
FDA expedites Modella AI PathChat DX development
Feb 5, 2025 · Biomedical artificial intelligence company Modella AI has received FDA Breakthrough Device Designation for its generative biomedical AI co-pilot PathChat DX.. PathChat DX is an extension of the PathChat model developed by computational pathology centre Mahmood Lab. "PathChat DX represents a transformative step forward for pathologists at every stage of their career.
Mito-rOCR assay kit by Agilent Technologies | Scientist Live
Jan 7, 2025 · The solution allows researchers to assess mitochondrial respiration. Software company Agilent Technologies has recently unveiled its Mito-rOCR Assay Kit.. The Mito-rOCR assay measures cells’ relative oxygen consumption rate (rOCR), enabling sensitive detection of changes in mitochondrial function.
FDA Approves Vertex's Alyftrek | Scientist Live
Jan 2, 2025 · The US Food and Drug Administration (FDA) has approved Vertex Pharmaceutical's new prooduct Alyftrek, a once-daily next-in-class triple combination cystic fibrosis transmembrane conductance regulator (CFTR) modulator for the treatment of cystic fibrosis (CF) in people six years and older.. The product is aimed at people who have at least one F508 mutation or another mutation in the CFTR gene ...
Binder launches cooling incubators and climate chambers
Jan 28, 2025 · Simulation chamber specialist Binder has launched a range of cooling incubators and constant climate chambers.. Suitable for a variety of applications including microbiology and pharmaceutical quality assurance, Binder’s new Pro units include KB, …
Scientist Live | Science news, opinion, interviews and product …
Progressive pulmonary fibrosis partnership between Qureight and Avalyn Pharma . Using core imaging platform technology, researchers aim to find effective treatments
First long-acting malaria injection administered to volunteers
Nov 12, 2024 · The first long-acting injectable (LAI) for malaria prevention has been administered to volunteers in a clinical trial for drug manufacturer Quotient Sciences and nonprofit Medicines for Malaria Venture (MMV). “This trial brings us closer to our goal of offering a long-lasting, affordable solution for malaria prevention,” said vice president of experimental medicine and clinical ...
Johnson & Johnson to acquire Intra-Cellular Therapies
Jan 20, 2025 · Johnson & Johnson has entered into a definitive agreement under which it will acquire all outstanding shares of Intra-Cellular Therapies, a biopharmaceutical company focused on the development and commercialisation of therapeutics for central nervous system (CNS) disorders, for $132.00 per share in cash for a total equity value of approximately $14.6 billion.